We are live on ! Find out more
GC

Greencape Capital Portfolio holdings

AUM $59.9M
1-Year Est. Return 23.92%
This Fund
S&P 500
This Quarter Est. Return
+4%
1 Year Est. Return
-23.92%
3 Year Est. Return
+98.13%
5 Year Est. Return
+205.92%
10 Year Est. Return
–
AUM
$282M
AUM Growth
+$53.4M
Cap. Flow
+$42.7M
Cap. Flow %
15.13%
Top 10 Hldgs %
100%
Holding
8
New
3
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$44.2M
2
AMCR icon
Amcor
AMCR
+$23.2M
3
META icon
Meta Platforms (Facebook)
META
+$8.5M
4
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$3.59M
5
NVDA icon
NVIDIA
NVDA
+$1.55M

Top Sells

Rank Stock Value
1
BMS
Bemis
BMS
+$22.8M
2
BCO icon
Brink's
BCO
+$15.5M

Sector Composition

Rank Sector Weight
1 Industrials 37.11%
2 Technology 21.35%
3 Healthcare 17.9%
4 Consumer Discretionary 17.46%
5 Communication Services 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCO icon
1
Brink's
BCO
$4.59B
$105M 37.11%
1,291,147
-195,200
-13% -$15.5M
NVDA icon
2
NVIDIA
NVDA
$5.2T
$60.3M 21.35%
14,685,000
+374,000
+3% +$1.55M
ABT icon
3
Abbott
ABT
$202B
$47.2M 16.71%
+561,000
New +$44.2M
EXPE icon
4
Expedia Group
EXPE
$38.6B
$25.3M 8.94%
189,821
– –
AMCR icon
5
Amcor
AMCR
$22.5B
$24M 8.52%
+418,612
New +$23.2M
META icon
6
Meta Platforms (Facebook)
META
$1.4T
$17.5M 6.18%
90,464
+46,500
+106% +$8.5M
MNTA
7
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$3.37M 1.19%
+270,280
New +$3.59M
BMS
8
DELISTED
Bemis
BMS
– –
-410,404
Closed -$22.8M

Similar funds

TCM
Tanaka Capital Management New York $59.9M AUM
ACM
AREX Capital Management New York $60.5M AUM 45.91% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
HPM
HealthCor Partners Management Charleston, South Carolina $50.7M AUM
IPHI
Inflection Point Holdings II New York $47.3M AUM
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Greencape Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Greencape Capital held 8 positions worth $282M, up 23% from $229M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Greencape Capital deployed $42.7M of net new capital in Q2 2019, opening 3 new positions and adding to 2 existing holdings. Its largest new stake was Abbott: 561,000 shares worth $47.2M.

By sector, the portfolio is most concentrated in Industrials at 37% of assets, down from 49% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Brink's, an estimated $15.5M trimmed.

  • Greencape Capital's largest Q2 2019 buy was Abbott: 561,000 shares worth $47.2M.
  • Greencape Capital added most to Meta Platforms (Facebook) in Q2 2019, an estimated $8.5M increase.
  • Greencape Capital's biggest Q2 2019 reduction was Brink's, cutting an estimated $15.5M.
  • Greencape Capital fully exited Bemis in Q2 2019, selling an estimated $22.8M.
  • Greencape Capital's ten largest holdings make up 100% of its $282M portfolio in Q2 2019.
  • Greencape Capital opened 3 new positions and closed 1 in Q2 2019.
  • Greencape Capital's portfolio value rose 23% quarter-over-quarter to $282M.

Based on Greencape Capital's 13F filing for Q2 2019, filed 6 Aug 2019.